Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma-Reference-Cited by-同舟云学术

Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma

Published:2013-12 Issue:6 Volume:59 Page:1193-1199
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Rodríguez-Perálvarez Manuel,Tsochatzis Emmanuel,Naveas María Carmen,Pieri Giulia,García-Caparrós Carmen,O’Beirne James,Poyato-González Antonio,Ferrín-Sánchez Gustavo,Montero-Álvarez Jose Luis,Patch David,Thorburn Douglas,Briceño Javier,De la Mata Manuel,Burroughs Andrew Kenneth

Publisher

Elsevier BV

Subject

Hepatology

Reference25 articles.

1. Management of hepatocellular carcinoma;Bruix;Hepatology,2005

2. Recurrent hepatocellular carcinoma after liver transplantation – an emerging clinical challenge;Welker;Transpl Int,2013

3. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

4. Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor progression;Maluccio;Transplantation,2003

5. Rho-associated kinase inhibitor reduces tumor recurrence after liver transplantation in a rat hepatoma model;Ogawa;Am J Transplant,2007

Cited by 194 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges related to clinical decision-making in hepatocellular carcinoma recurrence post-liver transplantation: Is there a hope?;World Journal of Transplantation;2024-09-18

2. Challenges in Liver Transplantation for Hepatocellular Carcinoma: A Review of Current Controversies;Cancers;2024-09-02

3. S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV);Zeitschrift für Gastroenterologie;2024-09

4. Reappraisal of tacrolimus levels after liver transplant for HCC: A multicenter study toward personalized immunosuppression regimen;Liver Transplantation;2024-08-23

5. Recurrence risk prediction models for hepatocellular carcinoma after liver transplantation;Journal of Gastroenterology and Hepatology;2024-08-07